Dosimetric Performance Analysis of Pediatric Based Halcyon™ Volumetric Arc Therapy-Based Lung-Sparing Total Body Irradiation.

That said, early follow-up studies of patients treated with VMAT TBI may suggest an overall trend towards lower rates of level 3+ pneumopathies compared to traditional TBI. 27 A recent retrospective study reported that only 4 of 32 patients (12.5%) receiving myeloablative VMAT TBI had grade 3+ pneumonitis, with 3 in the setting of documented respiratory infection and only 1 (3.1%) believed

also in 4,871 other papers